Moving Breast Cancer Treatments FORWARD
Registration is open for JKTG Foundation’s annual cancer research symposium held virtually October 28, 2021 from 1 – 3:30 p.m. EST. This year’s presentations and discussions will focus on immune cells and metastasis.
One of the world’s leading cancer researchers, Lisa Coussens, PhD, will deliver the Jayne Koskinas Memorial Lecture. A panel featuring researchers from Johns Hopkins University School of Medicine and Indiana University will round out the event.
“By convening a distinguished group to talk possibilities, discoveries and the research behind both, we get one step closer to better health care for those diagnosed with cancer,” said Ted Giovanis, founder and president of JKTG Foundation. “The Foundation strongly believes in the power of collaboration and events such as this give an opportunity for traditionally siloed research to creatively question traditional thinking and transform how we diagnose and treat cancer.”
Sponsored by the JKTG Foundation, the event is supported the Foundation for the National Institutes of Health.
Featured news
Ted‘s Take: Power in Perspective – or Academia versus the Real World
There’s an old adage – them that can do – do. Them that can’t do – teach. Many institutions and academia generally rely on credentialed academicians equating credentials with mastery of a subject area.
Ted’s Take: Have you ever suggested firing yourself? I have.
Have you ever suggested firing yourself? It’s worth asking the question of yourself – particularly if you’re a healthcare leader today.
Dedication of the Giovanis Institute for Translational Cell Biology
JKTG Founder and President Ted Giovanis, leading researchers, and University leaders gathered at the Johns Hopkins Welch Medical Library this week to formally mark the dedication of the Giovanis Institute for Translational Cell Biology – a symbolic first step of this important cancer research program.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133